| pubmed-article:10816550 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10816550 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:10816550 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
| pubmed-article:10816550 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
| pubmed-article:10816550 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:10816550 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:10816550 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10816550 | pubmed:dateCreated | 2000-6-23 | lld:pubmed |
| pubmed-article:10816550 | pubmed:abstractText | Human serum at low concentrations inhibits the growth of Cryptococcus neoformans in vitro. Fractionation of serum yielded a purified inhibitory protein with a molecular mass of approximately 81.8 kDa, a pI of approximately 6.2, and an amino acid sequence that matched that of human transferrin. The inhibitory activity and that of apotransferrin and 5% human serum were reversed by 10 microM freshly prepared FeCl(3). | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10816550 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10816550 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10816550 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10816550 | pubmed:issn | 0019-9567 | lld:pubmed |
| pubmed-article:10816550 | pubmed:author | pubmed-author:StevensD ADA | lld:pubmed |
| pubmed-article:10816550 | pubmed:author | pubmed-author:SridharSS | lld:pubmed |
| pubmed-article:10816550 | pubmed:author | pubmed-author:BrummerEE | lld:pubmed |
| pubmed-article:10816550 | pubmed:author | pubmed-author:AhluwaliaMM | lld:pubmed |
| pubmed-article:10816550 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10816550 | pubmed:volume | 68 | lld:pubmed |
| pubmed-article:10816550 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10816550 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10816550 | pubmed:pagination | 3787-91 | lld:pubmed |
| pubmed-article:10816550 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:meshHeading | pubmed-meshheading:10816550... | lld:pubmed |
| pubmed-article:10816550 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10816550 | pubmed:articleTitle | Characterization of an anticryptococcal protein isolated from human serum. | lld:pubmed |
| pubmed-article:10816550 | pubmed:affiliation | Division of Infectious Diseases, Department of Medicine, Santa Clara Valley Medical Center, and California Institute for Medical Research, San Jose, California, USA. | lld:pubmed |
| pubmed-article:10816550 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10816550 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10816550 | lld:pubmed |
